|
|
|
| 1 |
6,974,583 |
Pantethinesulphonic acid and/or a salt thereof as a free-radical scavenger
|
| 2 |
6,932,988 |
Kit and method for migraine headache treatment
|
| 3 |
6,930,099 |
Composition for the treatment and prevention of endothelial dysfunction
|
| 4 |
6,919,325 |
Pharmaceutical compositions containing tiotropium salts and low-solubility
salmeterol salts
|
| 5 |
6,906,193 |
N-type calcium channel antagonists for the treatment of pain
|
| 6 |
6,897,205 |
Multi-particulate form of medicament, comprising at least two differently
coated forms of pellet
|
| 7 |
6,884,792 |
Bretylium compositions and kits and their use in preventing and treating
cardiovascular conditions
|
| 8 |
6,875,447 |
Parenteral dosage forms comprising a suspension of tramadol salt and
diclofenac salt
|
| 9 |
6,867,236 |
Method of preventing of delaying the onset and progression of Alzheimer's
disease and related disorders
|
| 10 |
6,833,362 |
Method and composition for the accelerated in vivo removal of ethanol
|
| 11 |
6,821,999 |
Methods for inhibiting the production of TSST-1
|
| 12 |
RE38,576 |
Stabilized aspirin compositions and method of preparation for oral and
topical use
|
| 13 |
6,770,263 |
Compositions and methods for the treatment of aches and pains
|
| 14 |
6,730,329 |
Zinc containing compositions for anti-viral use
|
| 15 |
6,727,235 |
Synergistic compositions for the selective control of tumor tissue
|
| 16 |
6,716,884 |
Pharmaceutical compositions for oral administration of phloroglucinol and
preparation thereof
|
| 17 |
6,706,703 |
Bis(5-aryl-2-pyridyl) derivatives
|
| 18 |
6,703,380 |
Prevention of cancer
|
| 19 |
RE38,443 |
Stabilized aspirin compositions and method of preparation of oral and
topical use
|
| 20 |
6,669,966 |
Compositions for facilitating skin growth and methods and articles using
same
|
| 21 |
6,610,745 |
Use of 2-hydroxy-4-trifluoromethyl-benzoic acid derivatives as inhibitors
of the activation of the nuclear transcription factor NF-KS
|
| 22 |
6,610,673 |
Solid dose forms containing bismuth
|
| 23 |
6,596,708 |
Composition for the treatment and prevention of endothelial dysfunction
|
| 24 |
6,582,961 |
Methods of protecting plants from pathogens
|
| 25 |
6,551,620 |
Pellet formulation for the treatment of the intestinal tract
|
| 26 |
6,544,968 |
Use of angiotensin II receptor antagonists for treating acute myocardial
infarction
|
| 27 |
6,525,038 |
Synergistic compositions for the selective control of tumor tissue
|
| 28 |
6,524,630 |
Use of cocoa procyanidins combined with acelylsalicyclic acid as an
anti-platelet therapy
|
| 29 |
6,521,271 |
Compositions and methods of treatment for skin conditions using extracts of
turmeric
|
| 30 |
6,511,968 |
Combination therapy for treating, preventing, or reducing the risks
associated with acute coronary ischemic syndrome and related conditions
|
| 31 |
6,509,377 |
Use of a 2-hydroxy-4-trifluoromethylbenzoic acid derivatives as inhibitors
of the activation of the nuclear transcription factor NF-.kappa.B
|
| 32 |
6,503,488 |
Topical compositions including deodorant compositions
|
| 33 |
6,488,928 |
Product for topical application containing a lipase and a hydroxy acid
precursor
|
| 34 |
6,475,526 |
Zinc containing compositions for anti-viral use
|
| 35 |
6,436,371 |
Oral composition
|
| 36 |
6,426,338 |
Therapy for constipation
|
| 37 |
6,423,696 |
Inhibition of arylamine N-acetyl transferase
|
| 38 |
6,414,025 |
Utilization of 2-hydroxy-4-trifluoromethylbenzoic acid derivatives as
inhibitors of the activation of the nuclear transcription factors
NF-.kappa..beta.
|
| 39 |
6,395,720 |
Synergistically acting compositions for selectively combating tumor tissue
|
| 40 |
6,384,023 |
Silicone gel containing salicylic acid
|
| 41 |
6,361,792 |
Lipid dispersions and methods of use
|
| 42 |
6,348,204 |
Cosmetic or dermatological composition containing at least one extract of
mulberry, at least one extract of skullcap and at least one salicylic acid
derivative
|
| 43 |
6,326,364 |
Use of 5-aminosalicylates as antimicrobial agents
|
| 44 |
6,323,188 |
Treatment and prevention of cardiovascular diseases, heart attack, and
stroke, primary and subsequent, with help of aspirin and certain vitamins
|
| 45 |
6,316,010 |
Cosmetic compositions
|
| 46 |
6,306,843 |
Method for producing stable acetylsalicylic acid solutions
|
| 47 |
6,284,802 |
Methods for regulating the condition of mammalian keratinous tissue
|
| 48 |
6,284,749 |
Preservative system for topically administrable pharmaceutical compositions
containing a fatty acid/amino acid soap
|
| 49 |
6,281,203 |
Cosmetic and/or dermatological composition containing salicyclic acid
derivative and its use
|
| 50 |
6,277,836 |
Methods and compositions for treating inflammatory bowel disease
|
